Red Flags to Watch For Prescribers who skip baseline labs, offer peptides without a clinical evaluation, or guarantee specific outcomes should raise concern
[2] NICE does recommend liraglutide (Saxenda) as an option for managing overweight/obesity in adults in Tier-3 services and with specific BMI criteria (TA664)
Prescribers are advised to: Review eGFR before initiating treatment and consult the relevant SmPC for renal-specific guidance Monitor renal function periodically during therapy, particularly in those with CKD, risk factors, or on nephroactive medicines Counsel patients on adequate hydration, especially during periods of illness or reduced oral intake Patients should always ensure their prescriber is aware of any kidney condition before starting any weight loss medication
Login Token: The Login Token is used for session-spanning recognition of users
Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder
They can be obtained from the corresponding author upon reasonable request
